FGF21 improves cognition by restored synaptic plasticity, dendritic spine density, brain mitochondrial function and cell apoptosis in obese-insulin resistant male rats
© 2016 Elsevier Inc. Fibroblast growth factor 21 (FGF21) is an endocrine hormone which exerts beneficial effects on metabolic regulation in obese and diabetic models. However, the effect of FGF21 on cognition in obese-insulin resistant rats has not been investigated. We hypothesized that FGF21 preve...
Saved in:
Main Authors: | Sa-nguanmoo P., Tanajak P., Kerdphoo S., Satjaritanun P., Wang X., Liang G., Li X., Jiang C., Pratchayasakul W., Chattipakorn N., Chattipakorn S. |
---|---|
Format: | Journal |
Published: |
2017
|
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84983605315&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/41566 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
FGF21 improves cognition by restored synaptic plasticity, dendritic spine density, brain mitochondrial function and cell apoptosis in obese-insulin resistant male rats
by: Piangkwan Sa-nguanmoo, et al.
Published: (2018) -
DPP-4 Inhibitor and PPARγ Agonist Restore the Loss of CA1 Dendritic Spines in Obese Insulin-resistant Rats
by: Sripetchwandee,J., et al.
Published: (2015) -
DPP-4 Inhibitor and PPARγ Agonist Restore the Loss of CA1 Dendritic Spines in Obese Insulin-resistant Rats
by: Sripetchwandee,J., et al.
Published: (2015) -
DPP-4 Inhibitor and PPARγ Agonist Restore the Loss of CA1 Dendritic Spines in Obese Insulin-resistant Rats
by: Sripetchwandee,J., et al.
Published: (2015) -
SGLT2-inhibitor and DPP-4 inhibitor improve brain function via attenuating mitochondrial dysfunction, insulin resistance, inflammation, and apoptosis in HFD-induced obese rats
by: Sa-nguanmoo P., et al.
Published: (2017)